Elanco Animal Health Inc represents a strong commitment to improving animal health and welfare. Their corporate philosophy is rooted in the belief that healthy animals contribute to a better world for both animals and humans. They strive to deliver innovative solutions and products that address the diverse needs of animals, including their nutrition, health, and well-being. Elanco Animal Health Inc is dedicated to ensuring the responsible and ethical use of their products, while providing exceptional value to their customers. They aim to foster strong partnerships within the animal health industry and continuously work towards advancements in animal care and sustainability.

Elanco Animal Health Inc is primarily present in multiple countries and regions worldwide. As a global company, Elanco operates in various parts of North America, including the United States and Canada. It also maintains a significant presence in Europe, with operations in several countries such as Germany, France, Spain, Italy, and the United Kingdom. Additionally, Elanco has a strong foothold in the Asia-Pacific region, with a focus on countries like China, Japan, Australia, and India. The company's broad international presence allows Elanco Animal Health Inc to cater to the diverse needs of animal health across different markets, showcasing its commitment to global growth and innovation.

Elanco Animal Health Inc has achieved several significant milestones in its history. Since its inception, the company has focused on improving animal health through its innovative products and solutions. One major milestone was its spin-off from Eli Lilly and Company in 2018, establishing Elanco as a standalone company dedicated solely to animal health. Elanco has continually expanded its portfolio of products and services, helping to address the diverse needs of farmers and veterinarians worldwide. Through strategic acquisitions and collaborations, the company has strengthened its position in the animal health industry. Moreover, Elanco's commitment to sustainability and responsible animal care has garnered recognition, earning it a place among the industry leaders.

Elanco Animal Health Inc, a leading animal health company, has a rich history and background. Established in 1954 as a division of Eli Lilly and Company, Elanco has grown into a standalone company dedicated to improving animal health and well-being. With a wide portfolio of products and services, Elanco offers solutions for livestock and pets, encompassing pharmaceuticals, vaccines, and medicated feed additives. The company's commitment to innovation and research has positioned it as a global leader in animal health, addressing the evolving needs of the industry. Elanco Animal Health Inc continues to advance animal health through sustainable practices and partnerships, ensuring healthier and happier animals worldwide.

The main competitors of Elanco Animal Health Inc in the market include Zoetis Inc, Merck Animal Health, and Boehringer Ingelheim.

Elanco Animal Health Inc is primarily active in the animal health industry.

The business model of Elanco Animal Health Inc is focused on providing comprehensive solutions for animal health and welfare. Elanco develops and manufactures a wide range of pharmaceutical products, vaccines, and nutritional products for both companion animals and livestock. The company aims to improve the health and well-being of animals by delivering innovative solutions that enhance their productivity and quality of life. Elanco's business model operates through research and development, manufacturing, marketing, and sales of animal health products globally. With a commitment to innovation and sustainability, Elanco Animal Health is dedicated to supporting the welfare of animals and the needs of their owners.

مُعامل القيمة السوقية إلى الأرباح لـ Elanco Animal Health هو ١٤٫٦٧.

مُعامِل القيمة إلى المبيعات Elanco Animal Health هو ١٫٥٠.

نقاط جودة AlleAktien لـ Elanco Animal Health هي 2/10.

المتوقعة Elanco Animal Health الإيرادات هي ٤٫٥١ مليارات USD.

صافي الربح المتوقعة Elanco Animal Health هو ٤٦٠٫٦٩ مليون. USD.

Elanco Animal Health Inc. is a global company that focuses on researching, developing, manufacturing, and marketing products and solutions for animal health. The company offers a wide range of products in the areas of animal health, animal nutrition, and animal production, and serves customers in over 90 countries worldwide.

يوزع Elanco Animal Health أرباحًا قدرها 0 USD من خلال عمليات توزيع موزعة على مدار السنة.

لا يمكن حساب الأرباح السنوية لـ Elanco Animal Health في الوقت الحالي أو أن الشركة لا توزع أرباحًا.

الرمز الدولي للأوراق المالية الخاص بـElanco Animal Health هو US28414H1032.

رمز WKN لـ Elanco Animal Health هو A2N6BH.

الرمز المُختصر لـ Elanco Animal Health هو ELAN.

خلال آخر 12 شهراً، دفعت Elanco Animal Health توزيعات أرباح بقيمة . وهذا يعادل عائد توزيعات أرباح يقارب . ومن المتوقع أن تدفع Elanco Animal Health خلال الـ12 شهراً القادمة توزيعات أرباح تقدر بـ0 USD.

نسبة توزيعات الأرباح الحالية لـ Elanco Animal Health هي .

Elanco Animal Health يدفع توزيعات أرباح ربع سنوية. يتم توزيعها في الأشهر .

Elanco Animal Health دفعت توزيعات الأرباح كل عام خلال الـ0 سنوات الماضية.

يُتوقع خلال الـ12 شهرًا القادمة توزيع أرباح بقيمة 0 USD. وهذا يعادل عائد توزيعات أرباح قدره 0 %.

Elanco Animal Health يُصنف ضمن قطاع 'الصحة'.

لكي تستلم آخر توزيعات أرباح بقيمة 0 USD من Elanco Animal Health المُعلن عنها في ٢٧‏/٩‏/٢٠٢٤، كان يجب أن تمتلك السهم في محفظتك قبل تاريخ الاستحقاق السابق في ٢٧‏/٩‏/٢٠٢٤.

تم توزيع آخر دفعة من الأرباح بتاريخ ٢٧‏/٩‏/٢٠٢٤.

في العام 2023، وزعت Elanco Animal Health 0 USD كأرباح أسهم.

يتم توزيع أرباح Elanco Animal Health بالعملة USD.